Earl L. Yager has been named to...
- Share via
Earl L. Yager has been named to the board of directors of Chad Therapeutics. Yager, 42, replaces Stanley Sklute, who resigned for personal reasons, the company said. Now chief financial officer and vice president of finance and administration, Yager will also replace Sklute as secretary of the corporation. Yager joined the firm in 1983.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.